---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-009035"
form_type: "8-K"
ticker: "NEPH"
cik: "0001196298"
company_name: "NEPHROS INC"
filed_at: "2025-03-04T23:59:59+00:00"
generated_at: "2026-05-25T12:58:09.020119+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Nephros CFO Krandel gets two stock options, bonus target raised to 30%

## Summary
- Amendment to CFO Judith Krandel's letter agreement grants options for 54,359 and 58,961 shares under 2024 Equity Incentive Plan.
- First option vests 25% on first anniversary, then quarterly over 3 years; second vests upon closing a strategic transaction adding ≥$4M annual revenue.
- Annual performance bonus target increased to 30% of base salary; options accelerate upon termination without cause.
- Grant date is 3rd business day after filing 2024 10-K; exercise price equals closing price on grant date.

## SEC filing metadata
- accession: 0001493152-25-009035
- form_type: 8-K
- ticker: NEPH
- cik: 0001196298
- company_name: NEPHROS INC
- filed_at: 2025-03-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1196298/000149315225009035/0001493152-25-009035-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1196298/000149315225009035/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-009035
- JSON: https://secwatch.observer/filing/0001493152-25-009035.json
- Plain text: https://secwatch.observer/filing/0001493152-25-009035.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.